A phase IB study of durvalumab with or without tremelimumab and platinum-doublet chemotherapy in advanced solid tumours: Canadian Cancer Trials Group Study IND226.

Juergens, Rosalyn A

A phase IB study of durvalumab with or without tremelimumab and platinum-doublet chemotherapy in advanced solid tumours: Canadian Cancer Trials Group Study IND226. [electronic resource] - Lung cancer (Amsterdam, Netherlands) 05 2020 - 1-11 p. digital

Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

1872-8332

10.1016/j.lungcan.2020.02.016 doi


Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Humanized--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Carboplatin--administration & dosage
Cisplatin--administration & dosage
Female
Follow-Up Studies
Humans
Male
Middle Aged
Neoplasms--drug therapy
Prognosis
Survival Rate